Lawsuit over Wegovy pill is 'wake-up call' for compounders, Novo counsel says

In an interview, a lawyer for the Danish drugmaker says compounding of the Wegovy pill is a "tipping point." ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

February 9, 2026 Check out STAT+

Sponsored By

Novo Nordisk STAT+ | Lawsuit against Hims & Hers should be 'wake-up call' for compounders, Novo chief counsel says In an interview, Novo Nordisk's chief counsel said the efforts to compound the Wegovy pill is a 'tipping point.' By Elaine Chen and Ed Silverman TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics STAT analysis: Trump says TrumpRx has the world's lowest drug prices, but many listed drugs are cheaper as generics elsewhere. By John Wilkerson, J. Emory Parker, Chelsea Cirruzzo, Elaine Chen, and Daniel Payne STAT+ | Eli Lilly to buy Orna Therapeutics for $2.4 billion Eli Lilly will pay up to $2.4 billion for the biotechnology firm, the latest in a string of deals that the pharmaceutical giant has made in the past year. By Matthew Herper Molly Ferguson for STAT STAT+ | Opinion: If you have Alzheimer's disease, who will take part in your care? As Alzheimer's and other dementias are diagnosed earlier and earlier, doctors must change how they discuss care. By Jason Karlawish STAT+ | Federal government turns to fresher data to rein in Medicare Advantage upcoding In using new data to set Medicare Advantage risk scores, federal government hints at areas where it believes insurance companies were using upcoding to game system. By Bob Herman STAT+ | Biotech doubles financing in quest to silence genes behind neurological diseases Aerska Therapeutics, based in Dublin and London, is focused on using 'brain shuttles' to deliver molecules past blood-brain barrier. By Allison DeAngelis EMMANUEL DUNAND/AFP via Getty Images Opinion: As a scientist and NFL widow, I am furious about a recent NFL Players Association-funded CTE study Ahead of the Super Bowl, a scientist looks at an NFL Players Association funded study suggesting CTE "awareness" is the real problem. By Eleanor M. Perfetto Opinion: How the Centers for Medicare and Medicaid Services became the shining light of Trump's second term While the rest of the health care system is in crisis, CMS stands out, making changes and innovating on the essential nonpartisan missions of the agency. By Ezekiel J. Emanuel and Merjan L. Ozisik

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser